Caplin Point Laboratories Limited has informed the Exchange regarding Cessation of Mr. Thiagaraja Manikandan as Chief Transformation & Digital Officer of the company w.e.f. April 21, 2025.
CAPLIPOINT · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 2.0 pts less than Nifty Smallcap 250 and 1.4 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Caplin Point Laboratories Limited has informed the stock exchange about the cessation of Mr. Thiagaraja Manikandan from the role of Chief Transformation & Digital Officer, effective April 21, 2025. The announcement marks the end of his tenure in this key managerial position at the company. No reason for the cessation has been disclosed in this filing. This is a senior-level exit involving a key managerial personnel (KMP) of the company.
This is a senior leadership exit that investors should monitor, as the role oversees transformation and digital strategy. The stock price may see minor short-term volatility, though the impact depends on succession plans and the reason behind the departure.